AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Males With DMD
ConditionDuchenne Muscular Dystrophy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age0-25
SponsorREGENXBIO Inc.
About this trial
This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).
Eligibility criteria
Qualifiers
Males at least 0 to <25 years of age
Diagnosis of DMD
Provision of signed and dated informed consent form (ICF) and assent as required per local regulations or requirements
Disqualifiers
Prior participation in a gene therapy trial OR recipient of a gene therapy drug
Other inclusion/exclusion criteria apply
Trial design
Treatments tested in this trial
- AAV8 DetectCDx
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov